Effects of dietary saturated and n-6 polyunsaturated fatty acids on the incorporation of long-chain n-3 polyunsaturated fatty acids into blood lipids

Eur J Clin Nutr. 2016 Jul;70(7):812-8. doi: 10.1038/ejcn.2015.213. Epub 2016 Jan 13.

Abstract

Background/objectives: Omega-3 polyunsaturated fatty acids (n-3PUFA) are better absorbed when they are combined with high-fat meals. However, the role of different dietary fats in modulating the incorporation of n-3PUFA in blood lipids in humans has not been previously explored. Omega-6 polyunsaturated fatty acids (n-6PUFA) are known to compete with n-3PUFA in the metabolic pathways and for the incorporation into phospholipids, whereas saturated fats (SFA) may enhance n-3PUFA incorporation into tissues.

Subjects/methods: In a randomized parallel-design trial, we aimed to investigate the long-term effects of n-3PUFA supplementation in subjects consuming a diet enriched with either SFA or n-6PUFA on fatty acid incorporation into plasma and erythrocytes and on blood lipid profiles (total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides).

Results: Dietary supplementation with n-3PUFA co-administered with SFA for 6 weeks resulted in a significant rise in total cholesterol (0.46±0.60 mmol/L; P=0.020) and LDL-C (0.48±0.48 mmol/L; P=0.011) in comparison with combination with n-6PUFA. The diet enriched with SFA also induced a greater increase in eicosapentaenoic acid (2.07±0.79 vs 1.15±0.53; P=0.004), a smaller decrease in docosapentaenoic acid (-0.12±0.23 vs -0.30±0.20; P=0.034) and a similar increase in docosahexaenoic acid (3.85±1.14 vs 3.10±1.07; P=0.128) percentage in plasma compared with the diet enriched with n-6PUFA. A similar effect was seen in erythrocytes. N-3PUFA supplementation resulted in similar changes in HDL-C and triglyceride levels.

Conclusions: The results suggest that dietary substitution of SFA with n-6PUFA, despite maintaining low levels of circulating cholesterol, hinders n-3PUFA incorporation into plasma and tissue lipids.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Diet*
  • Dietary Fats / blood
  • Dietary Fats / pharmacology*
  • Eicosapentaenoic Acid / blood
  • Erythrocytes / metabolism
  • Fatty Acids / blood
  • Fatty Acids / pharmacology*
  • Fatty Acids, Omega-3 / blood*
  • Fatty Acids, Omega-6 / adverse effects
  • Fatty Acids, Omega-6 / blood
  • Fatty Acids, Omega-6 / pharmacology*
  • Fatty Acids, Unsaturated / blood
  • Feeding Behavior*
  • Female
  • Humans
  • Lipids / blood*
  • Male
  • Middle Aged
  • Phospholipids / blood
  • Phospholipids / chemistry
  • Triglycerides / blood
  • Young Adult

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Dietary Fats
  • Fatty Acids
  • Fatty Acids, Omega-3
  • Fatty Acids, Omega-6
  • Fatty Acids, Unsaturated
  • Lipids
  • Phospholipids
  • Triglycerides
  • Cholesterol
  • Eicosapentaenoic Acid
  • docosapentaenoic acid